Relapsing remitting multiple sclerosis: genes and variants
Explore variant evidence for Relapsing remitting multiple sclerosis across 3 analyzed proteins (KEAP1, MS4A1, HNRNPA1). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Relapsing remitting multiple sclerosis
KEAP1: Kelch-like ECH-associated protein 1
It continuously targets NRF2 for degradation under basal conditions but releases this brake when reactive electrophiles or oxidative stress modify KEAP1. Somatic loss-of-function variants can lock tumors into a persistent antioxidant state that promotes survival and treatment resistance.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KEAP1 have source records linked to Relapsing remitting multiple sclerosis. Association strength is not clinical gene validity.
MS4A1: B-lymphocyte antigen CD20
Its expression spans much of B-cell development and contributes to calcium signaling and B-cell activation. Its stable surface expression makes it a major therapeutic target for B-cell depletion in lymphoma, leukemia, and autoimmune disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MS4A1 have source records linked to Relapsing remitting multiple sclerosis. Association strength is not clinical gene validity.
HNRNPA1: Heterogeneous nuclear ribonucleoprotein A1
It regulates pre-mRNA splicing, RNA transport, translation, and stress-granule dynamics through RNA binding and reversible self-assembly. Rare pathogenic variants can cause multisystem proteinopathy, amyotrophic lateral sclerosis, or related neuromuscular degeneration through altered RNA and protein homeostasis.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in HNRNPA1 have source records linked to Relapsing remitting multiple sclerosis. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Relapsing remitting multiple sclerosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HNRNPA1 M328L | 328 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
| HNRNPA1 N332S | 332 | Nuclear targeting sequence (M9) | Pathogenic / likely pathogenic |
Same protein, different disease
- Chronic progressive multiple sclerosis also has ClinVar records linked to HNRNPA1 variants; they fall mostly in different places as the Relapsing remitting multiple sclerosis variants (14 pathogenic / likely pathogenic).
Diseases related to Relapsing remitting multiple sclerosis
- Multiple sclerosis, also linked to KEAP1 and MS4A1
- Amyotrophic lateral sclerosis, also linked to HNRNPA1
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia, also linked to HNRNPA1
- Non-small cell lung carcinoma, also linked to KEAP1
- Chronic progressive multiple sclerosis, also linked to HNRNPA1
- Lung adenocarcinoma, also linked to KEAP1
- Acute lymphoid leukemia, also linked to MS4A1
Frequently asked questions
Which genes have records linked to Relapsing remitting multiple sclerosis?
This view contains 3 analyzed proteins: KEAP1, MS4A1, HNRNPA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 7 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center